Clinical Trials Directory

Trials / Terminated

TerminatedNCT04527796

Influence of a Residential Rehabilitation Program on Body Composition in Patients with Cystic Fibrosis

Influence of a Residential Rehabilitation Program on Body Composition in Patients with Cystic Fibrosis (children and Adults)

Status
Terminated
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

The aim is to evaluate the impact of a 3-week lasting residential rehabilitation program for patients with cystic fibrosis on their nutritional status measured as BMI and body composition and pulmonary function.

Detailed description

Cystic fibrosis Patients following a residential rehabilitation program consisting of dietary adaptation, physical therapy for airway drainage and supervised inhalation therapy and physical activity for at least 3 weeks are asked to participate. Weight, height, body composition and pulmonary function will be measured at start and end of the program. Dietary intake during the program is calculated based on a 2 day weighed intake diary and physical activity will be measured with the "SenseWear pro 3" armband.

Conditions

Interventions

TypeNameDescription
OTHERRehabilitationDuring the rehabilitation program a multidisciplinary team, consisting of a pneumologist, dietician, psychologist, social worker and several physiotherapists, coach the cystic fibrosis patients. The physiotherapists help with autogenic drainage and aerosol therapy (2-3 times/day) and supervise physical activity (5, 1-hour lasting, training sessions/week: swimming 2, Fitness training 2, 1 session of choice). The dietician calculates basal and theoretical energy needs . A carbohydrate-rich snack before exercise, to improve exercise tolerance and a carbohydrate-protein-rich snack afterwards to improve recuperation is provided.

Timeline

Start date
2018-09-01
Primary completion
2020-05-01
Completion
2020-07-01
First posted
2020-08-27
Last updated
2024-09-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04527796. Inclusion in this directory is not an endorsement.